These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8141084)

  • 21. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
    White HD
    Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy.
    Simoons ML; Maggioni AP; Knatterud G; Leimberger JD; de Jaegere P; van Domburg R; Boersma E; Franzosi MG; Califf R; Schröder R
    Lancet; 1993 Dec 18-25; 342(8886-8887):1523-8. PubMed ID: 7902905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there an age limit for thrombolytic therapy?
    Sleight P
    Am J Cardiol; 1993 Dec; 72(19):30G-33G. PubMed ID: 8279358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction.
    Al Khuwaitir TS; Wani BA; Dawood HA; Khan MA
    Saudi Med J; 2005 Jan; 26(1):130-2. PubMed ID: 15756370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracranial hemorrhage complicating acute myocardial infarction in the era of thrombolytic therapy.
    Conrad AR; Feffer SE; Rajan RT; Freeman I
    South Med J; 1997 Jan; 90(1):5-12. PubMed ID: 9003815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for wider utilization of thrombolytic therapy.
    Hennekens C
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III26-31. PubMed ID: 9422860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorrhagic complications of thrombolytic therapy.
    Lauer JE; Heger JJ; Mirro MJ
    Chest; 1995 Dec; 108(6):1520-3. PubMed ID: 7497754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombolytic therapy in acute myocardial infarct].
    Verstraete M
    Recenti Prog Med; 1990 Apr; 81(4):287-98. PubMed ID: 2198644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy: a review of its use in acute myocardial infarction.
    Bizjak ED; Mauro VF
    Ann Pharmacother; 1998; 32(7-8):769-84. PubMed ID: 9681094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction.
    Schröder K; Wegscheider K; Neuhaus KL; Tebbe U; Schröder R
    Heart; 1997 Jun; 77(6):506-11. PubMed ID: 9227292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
    Mahaffey KW; Granger CB; Collins R; O'Connor CM; Ohman EM; Bleich SD; Col JJ; Califf RM
    Am J Cardiol; 1996 Mar; 77(8):551-6. PubMed ID: 8610601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored thrombolytic therapy. A perspective.
    Simoons ML; Arnold AE
    Circulation; 1993 Dec; 88(6):2556-64. PubMed ID: 8252667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical risks of thrombolytic therapy.
    Califf RM; Fortin DF; Tenaglia AN; Sane DC
    Am J Cardiol; 1992 Jan; 69(2):12A-20A. PubMed ID: 1729875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument.
    Selker HP; Griffith JL; Beshansky JR; Schmid CH; Califf RM; D'Agostino RB; Laks MM; Lee KL; Maynard C; Selvester RH; Wagner GS; Weaver WD
    Ann Intern Med; 1997 Oct; 127(7):538-56. PubMed ID: 9313022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolytic therapy and cocaine-associated acute myocardial infarction.
    Boniface KS; Feldman JA
    Am J Emerg Med; 2000 Sep; 18(5):612-5. PubMed ID: 10999580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results.
    Selker HP; Beshansky JR; Schmid CH; Griffith JL; Longstreth WT; O'Connor CM; Caplan LR; Massey EW; D'Agostino RB; Laks MM
    Circulation; 1994 Oct; 90(4):1657-61. PubMed ID: 7923649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study).
    Taylor GJ; Moses HW; Koester D; Colliver JA; Katholi RE; Dove JT; Woodruff RC; Mikell FL; Becker LC; Sheehan FH
    Am J Cardiol; 1993 Nov; 72(14):1010-4. PubMed ID: 8213579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining the risk-benefit equation for thrombolysis: how to identify the low risk patient before administering thrombolytic therapy.
    Nidorf M; Parsons R; Thompson P; Jamrozik K; Hobbs M
    Aust N Z J Med; 1998 Aug; 28(4):525-8. PubMed ID: 9777133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.